🇺🇸 FDA
Pipeline program

Hypofraction radiation

GLMU-03

Unknown other completed

Quick answer

Hypofraction radiation for Nasopharyngeal Carcinoma is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Nasopharyngeal Carcinoma
Phase
Unknown
Modality
other
Status
completed

Clinical trials